BRD7 Rekombinanter Antikörper
BRD7 Rekombinant Antikörper für WB, Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human, Maus
Anwendung
WB, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
250776B2
Kat-Nr. : 86176-2-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
86176-2-PBS bindet in WB, Indirect ELISA BRD7 und zeigt Reaktivität mit human, Maus
Getestete Reaktivität | human, Maus |
Wirt / Isotyp | Kaninchen / IgG |
Klonalität | Rekombinant |
Typ | Antikörper |
Immunogen | BRD7 fusion protein Ag1461 |
Vollständiger Name | bromodomain containing 7 |
Berechnetes Molekulargewicht | 651 aa, 74 kDa |
Beobachtetes Molekulargewicht | 74-78 kDa |
GenBank-Zugangsnummer | BC050728 |
Gene symbol | BRD7 |
Gene ID (NCBI) | 29117 |
Konjugation | Unkonjugiert |
Form | Liquid |
Reinigungsmethode | Protein-A-Reinigung |
Lagerungspuffer | PBS only |
Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
BRD7 (bromodomain containing 7), is a subunit of poly-bromo-associated BRG1-associated factor (PBAF)-specific Swi/Snf chromatin remodeling complexes.BRD7 is proposed as a tumor suppressor protein, since its identification as an important component of both functional p53 and BRCA1 (breast cancer 1, early onset) pathways. BRD7 could down-regulate the GSK3beta phosphotransferase activity as dephosphorylation of GSK3B at 'Tyr-216', thus activate the Wnt signaling pathway in a DVL1-dependent manner.